Let CHIPOR chip away at the problems in your healthcare system.
The Samford University Center for Healthcare Innovation and Patient Outcomes Research (CHIPOR) was established to design and support scholarly activities that promote innovative models which improve patient care.
There is a unique need to identify contributors to rising healthcare costs and medical misadventures and provide practical solutions to stakeholders. CHIPOR can be instrumental in identifying issues related to the break down in the healthcare system and offering suggestions to circumvent challenges facing the individuals that are affected. CHIPOR faculty are well versed in the areas of epidemiology, biostatistics, literature evaluation and research design to make a profound impact on the dissemination of information in this area.
To design and support scholarly activities that promote innovative models which improve patient care.
Healthcare costs in the United Sates are increasing at an alarming rate. According to the Kaiser Family Foundation, the gross domestic product (GDP) for healthcare increased from 7.2% in 1970 to 17.9% in 2009/2010. The United States spent $2.6 trillion in healthcare in 2010, which amounts to approximately $8,402 per person. This increase may be due predominantly to new technologies, including prescription drug products, used to treat these disease states. Prescription drug costs only accounts for 10% of healthcare expenditures, however, prescription drug expenditures increased 114% from 2000 to 2010.
The current healthcare model that is used in the United States is unsustainable. As a result, policy makers and others are trying to determine a better way to deliver the most appropriate care efficiently. Although the Affordable Care Act was implemented to gain better efficiencies in the healthcare system, important challenges remain that prohibit the rapid reduction of health-care related GDP to a sustainable amount.
In addition to these challenges, medication misadventures continue to have a deleterious effect on patient health. Drug-related injuries are associated with $3.5 billion excess per year. In addition, morbidity and mortality associated with medication adventures is estimated to be $77 billion per year.
Evaluate specific resources used (e.g., drug products) and the rates that the resources are consumed.
Evaluate the compliance level of standards of care (e.g., time frame associated with receipt of antibiotics prior to surgery).
Evaluate the impact of health care delivery on patient health (e.g., mortality rates, achievement of therapeutic goals [HgbA1c, blood pressure, etc]).
Identify problem (e.g., those associated with high variation) that may impact patient health or are associated with excessive cost. Determine ways to solve potential problems and measure the effects over time.
Assist facilities in managing own performance and help identify areas of improvement.
Assess claims data to help payers identify populations who may benefit from pharmacist intervention services.
Neither Samford University nor its trustees, employees, volunteers or affiliates (“Samford”) is dispensing medical advice or pharmacy consultation services through CHIPOR. The information provided throughout the Site is not intended to be a replacement for appropriate medical and/or pharmacy care. Any information regarding drug usage, medical interpretation, and/or drug literature analysis strictly represents the opinions of the faculty and staff providing such information.
Users of the Site do so at their own risk. While faculty and staff make every effort to ensure the accuracy and timeliness of the information contained on the Site, there is no guaranty that the information provided is accurate, current or applicable to any specific individual. Accordingly, Samford shall not be responsible for the continued currency of the information, discrepancies, or errors appearing on the Site and shall in no event be liable for injuries (including death) to any party which may occur as a result of reliance upon any materials provided on the Site, the misinterpretation thereof or adverse drug reactions that may occur.
CHIPOR funding is provided by the McWhorter School of Pharmacy, Samford University, and contractual clients. There are no known conflicts of interest associated with CHIPOR receiving funding from these sources.
Advertising via the Site is prohibited and no visitor tracking mechanisms are utilized.
The Site may include links to third-party web sites; however, Samford does not endorse the content of such websites. Samford is not responsible for the content of linked third-party sites, or third-party advertisements, and does not make any representations regarding their content or accuracy. Use of third-party websites is at the user’s own risk and subject to the terms and conditions of use for such sites. Samford does not endorse any product, service, or treatment appearing on the Site.